vs

Side-by-side financial comparison of A10 Networks, Inc. (ATEN) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $75.0M, roughly 1.7× A10 Networks, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 13.4%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 11.7%).

A10 Networks, Inc. is an American public company specializing in the manufacturing of application delivery controllers. Founded in 2004 by Lee Chen, co-founder of Foundry Networks, A10 originally serviced just the identity management market with its line of ID Series products. In early 2007, they added bandwidth management appliances. The company had its initial public offering on March 21, 2014, raising $187.5 million.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

ATEN vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.7× larger
ZLAB
$127.1M
$75.0M
ATEN
Growing faster (revenue YoY)
ZLAB
ZLAB
+3.7% gap
ZLAB
17.1%
13.4%
ATEN
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
11.7%
ATEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ATEN
ATEN
ZLAB
ZLAB
Revenue
$75.0M
$127.1M
Net Profit
$12.0M
Gross Margin
79.6%
51.0%
Operating Margin
17.3%
-54.6%
Net Margin
16.0%
Revenue YoY
13.4%
17.1%
Net Profit YoY
EPS (diluted)
$0.17
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$75.0M
Q4 25
$80.4M
$127.1M
Q3 25
$74.7M
$115.4M
Q2 25
$69.4M
$109.1M
Q1 25
$66.1M
$105.7M
Q4 24
$74.2M
$108.5M
Q3 24
$66.7M
$101.8M
Q2 24
$60.1M
$100.1M
Net Profit
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$12.0M
Q4 25
$9.9M
Q3 25
$12.2M
$-36.0M
Q2 25
$10.5M
$-40.7M
Q1 25
$9.5M
$-48.4M
Q4 24
$18.3M
Q3 24
$12.6M
$-41.7M
Q2 24
$9.5M
$-80.3M
Gross Margin
ATEN
ATEN
ZLAB
ZLAB
Q1 26
79.6%
Q4 25
78.7%
51.0%
Q3 25
80.1%
59.5%
Q2 25
78.9%
60.6%
Q1 25
79.7%
63.6%
Q4 24
79.9%
61.5%
Q3 24
80.5%
64.1%
Q2 24
80.0%
64.9%
Operating Margin
ATEN
ATEN
ZLAB
ZLAB
Q1 26
17.3%
Q4 25
18.7%
-54.6%
Q3 25
17.4%
-42.3%
Q2 25
14.9%
-50.3%
Q1 25
13.3%
-53.3%
Q4 24
24.8%
-62.6%
Q3 24
15.7%
-66.6%
Q2 24
13.2%
-76.0%
Net Margin
ATEN
ATEN
ZLAB
ZLAB
Q1 26
16.0%
Q4 25
12.3%
Q3 25
16.3%
-31.2%
Q2 25
15.2%
-37.3%
Q1 25
14.4%
-45.8%
Q4 24
24.7%
Q3 24
18.9%
-40.9%
Q2 24
15.8%
-80.2%
EPS (diluted)
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$0.17
Q4 25
$0.13
$-0.05
Q3 25
$0.17
$-0.03
Q2 25
$0.14
$-0.04
Q1 25
$0.13
$-0.04
Q4 24
$0.24
$-0.09
Q3 24
$0.17
$-0.04
Q2 24
$0.13
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEN
ATEN
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$57.9M
$689.6M
Total DebtLower is stronger
$219.2M
Stockholders' EquityBook value
$220.8M
$715.5M
Total Assets
$634.4M
$1.2B
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$57.9M
Q4 25
$684.6M
$689.6M
Q3 25
$370.9M
$717.2M
Q2 25
$367.4M
$732.2M
Q1 25
$355.8M
$757.3M
Q4 24
$195.6M
$779.7M
Q3 24
$182.1M
$616.1M
Q2 24
$177.1M
$630.0M
Total Debt
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$219.2M
Q4 25
$218.8M
Q3 25
$218.4M
Q2 25
$218.1M
Q1 25
$217.7M
Q4 24
$0
Q3 24
Q2 24
Stockholders' Equity
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$220.8M
Q4 25
$211.5M
$715.5M
Q3 25
$206.2M
$759.9M
Q2 25
$204.0M
$791.7M
Q1 25
$195.9M
$810.8M
Q4 24
$231.8M
$840.9M
Q3 24
$217.3M
$667.7M
Q2 24
$214.4M
$704.2M
Total Assets
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$634.4M
Q4 25
$629.8M
$1.2B
Q3 25
$620.1M
$1.2B
Q2 25
$607.9M
$1.2B
Q1 25
$606.2M
$1.2B
Q4 24
$432.8M
$1.2B
Q3 24
$407.7M
$985.3M
Q2 24
$397.2M
$987.4M
Debt / Equity
ATEN
ATEN
ZLAB
ZLAB
Q1 26
0.99×
Q4 25
1.03×
Q3 25
1.06×
Q2 25
1.07×
Q1 25
1.11×
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEN
ATEN
ZLAB
ZLAB
Operating Cash FlowLast quarter
$2.2M
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
3.9%
0.5%
Cash ConversionOCF / Net Profit
0.19×
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEN
ATEN
ZLAB
ZLAB
Q1 26
$2.2M
Q4 25
$22.7M
$-26.0M
Q3 25
$22.8M
$-32.0M
Q2 25
$22.2M
$-31.0M
Q1 25
$17.2M
$-61.7M
Q4 24
$25.7M
$-55.8M
Q3 24
$20.1M
$-26.8M
Q2 24
$12.2M
$-42.2M
Free Cash Flow
ATEN
ATEN
ZLAB
ZLAB
Q1 26
Q4 25
$16.0M
$-26.7M
Q3 25
$18.1M
$-35.0M
Q2 25
$17.9M
$-33.9M
Q1 25
$12.7M
$-63.2M
Q4 24
$23.3M
$-58.4M
Q3 24
$16.7M
$-28.2M
Q2 24
$8.7M
$-42.9M
FCF Margin
ATEN
ATEN
ZLAB
ZLAB
Q1 26
Q4 25
20.0%
-21.0%
Q3 25
24.2%
-30.4%
Q2 25
25.9%
-31.1%
Q1 25
19.2%
-59.9%
Q4 24
31.4%
-53.8%
Q3 24
25.0%
-27.7%
Q2 24
14.5%
-42.9%
Capex Intensity
ATEN
ATEN
ZLAB
ZLAB
Q1 26
3.9%
Q4 25
8.3%
0.5%
Q3 25
6.3%
2.6%
Q2 25
6.1%
2.6%
Q1 25
6.8%
1.5%
Q4 24
3.2%
2.4%
Q3 24
5.2%
1.3%
Q2 24
5.8%
0.7%
Cash Conversion
ATEN
ATEN
ZLAB
ZLAB
Q1 26
0.19×
Q4 25
2.30×
Q3 25
1.87×
Q2 25
2.10×
Q1 25
1.80×
Q4 24
1.40×
Q3 24
1.59×
Q2 24
1.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATEN
ATEN

Products$44.0M59%
Services$31.0M41%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons